Meeting room at Oslo Science Park: Toppsenteret

Hear Nordic and international investors and thought leaders reflect around the Norwegian and Nordic investment landscape, and meet investors and life science companies for 1:1 partnering.

How do investors look at the challenges and opportunities that come with them?

Learn how Norwegian life science is well positioned to contribute to the next generation of solutions to human and planetary health, and how the Nordics is well positioned for a sustainable and digital life science industry.

Last year’s conference brought ca. 140 participants and nearly 100 1:1 meetings between investors and companies.

Programme

Moderator of the day: Anne Ulvestad, Founding Executive Director, INNOSIAMO

08:00 – 09:00

Breakfast & Registration

09:00 – 09:15

Opening Remarks – The Investment Reset, Capital Shifts Across Life Science 

Delphine Costa, CEO, The Life Science Cluster & Shokouh Makvandi-Nejad, Head of Investments and Strategic Projects, The Life Science Cluster 

Keynote: The Life Science Investor Playbook for the Next Decade

09:15 – 09:35

The state of venture capital in Norway

Allon Groth, Managing Director, NVCA – Norwegian Venture Capital and Private Equity Association

09:35 – 9:55

Title TBA

Ricardo Gaminha Pacheco, Longevity Biotech Lead, Insilico Medicine

9:55 – 10:15

Panel Discussion: The Future of Life Science Capital, Where Investment Is Moving and Why It Matters

Moderator: Tone Varslot Stave, Head of health, Innovation Norway

• Sebastian Gensior, Managing Director, Capital for Cures
• Georgina Askeland, Principal, Hadean Ventures
• Damián Carvajal Ibáñez, Partnering Manager – Strategic Partnering S&E Oncology, Debiopharm

10:15 – 10:45

Coffee Break & 1:1 partnering

10:45 – 11:05 

Strategic Capital in Life Sciences: How Pharma Invests, Partners, and Helps Scale Innovation Globally

Sergio Capancioni, Director Search & Evaluation, International, AbbVie

11:05 – 11:55 

Reverse Pitch Session: Meet the Investors

• Karina Wessel, Impact Manager, Bluefront Equity
• Linn-Cecilie Linnemann, Senior Partner, LUMO Labs
• Gisle Østereng, Head of Investments, StartupLab
• May Hald, Head of Investor Relations, Investigate
• Nermina Eek, Investment Director, DNV Ventures
• Tanja Knabenschuh Hoel, General Manager, Hatch Blue
• Sebastian Gensior, Managing Director, Capital for Cures
• Marko Kuisma, Partner, Innovestor
• Damián Carvajal Ibáñez, Partnering Manager, Debiopharm
• Angela Holter, Founding Partner, Chair of the Board, Investor, WIN Ventures

11:55 – 12:50 

Networking Lunch & 1:1 Partnering

12:50 – 13:10

Nordic Scale-Up Spotlight (a success story): Building Global Impact from a Small Market

Erik Tveterås, CFO, Norwegian Mycelium (NoMy) & Øystein Soug, CEO, Oncoinvent

13:10 – 13:25: Short Coffee Break

13:25 – 13:45

Parallel sessions   

Panel A: Building Investable Bio-Innovation: What Investors Look for in Sustainable and Blue-Green Life Sciences (location: H2B)

Moderator: Tonje Ørnholt, Founder, ØRN Advisory

• Tanja Knabenschuh Hoel, General Manager, Hatch Blue
• Jean-Guillaume Marquaire, Investment Director, Wilstar Innovate
• Karina Wessel, Impact Manager, Bluefront Equity

Panel B: Funding Advanced Therapeutics: From Breakthrough Science to Scalable, Affordable Healthcare (location: Toppsenteret)

Moderator: TBA

• Anesa Mulabecirovic, DNB Asset Management, DNB Healthcare and DNB Biotechnology
• Adam Robertson, CSO, Hemispherian
• Ane Tolnes Haugdal, Investment Manager, Investinor

13:45 – 14.00: Coffee Break & 1:1 Partnering

14:00 – 14:30

New funding opportunities for Nordic life science 

Anne Maria Eikeset & Andrew W. Lo

14:30 – 14:50

Panel Discussion: AI, Data, and Automation in Life Sciences, Hype vs Investable Reality

Moderator: Anjali Bhatnagar, Advisor, Investor, Serial founder, Growcraft

• Marko Kuisma, Partner, Innovestor
• Nermina Eek, Investment Director, DNV Ventures
• Arne Tonning, Partner, Alliance Ventures
• Torbjørn Furuseth, CEO and Co-founder, DoMore Diagnostics

14:50 – 15:00

Closing Reflections: What Founders Should Prioritise in the Next Funding Cycle

Delphine Costa, CEO, The Life Science Cluster

15:00 – 16:00

Networking, Follow-Up Meetings & 1:1 Partnering

16.00

Partnering end

16.00 – 18.00

Rooftop reception with finger food and refreshments